<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - A systematic EU approach to chronic kidney disease (debate) - Thursday, 10 March 2022</title><meta name="title" content="Verbatim report of proceedings - A systematic EU approach to chronic kidney disease (debate) - Thursday, 10 March 2022" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2022 - Source: European Parliament" /><meta name="available" content="10-03-2022" /><meta name="sipade-leg" content="9" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - A systematic EU approach to chronic kidney disease (debate) - Thursday, 10 March 2022" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-9-2022-03-10-ITM-014_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li><a title="bg - български" class="bg on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_BG.html">bg - български</a></li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_FR.html">fr - français</a></li>
            <li><a title="ga - Gaeilge" class="ga on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_GA.html">ga - Gaeilge</a></li>
            <li><a title="hr - hrvatski" class="hr on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_HR.html">hr - hrvatski</a></li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_PT.html">pt - português</a></li>
            <li><a title="ro - română" class="ro on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_RO.html">ro - română</a></li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-9-2022-03-10-ITM-014_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2022-03-10-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2022-03-10-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2022-03-10-ITM-013_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2022-03-10-ITM-013_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-9-2022-03-10-ITM-015_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-9-2022-03-10-ITM-015_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-9-2022-03-10_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-9-2022-03-10_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table><table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)">
<table border="0" cellspacing="0" cellpadding="0"><tr>
<td><a href="/doceo/document/CRE-9-2022-03-10-ITM-014_EN.xml"><img src="/doceo/data/img/formats/icn_xml.gif" border="0" align="bottom" alt="XML" title="XML" /></a><span class="doc_size"> 37k</span></td></tr>
</table></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Thursday, 10 March 2022 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">Revised edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 14. A systematic EU approach to chronic kidney disease (debate)</td><td style="background-image:url(/doceo/data/img/gradient_blue.gif)" width="10"><table cellSpacing="0" cellPadding="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:01:10&amp;playerEndTime=20220310-15:38:15" target="_blank"><img width="29" height="20" src="/doceo/data/img/vod_all_speakers_left.gif" border="0" /></a></td><td class="switch_button_pv_cre"><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:01:10&amp;playerEndTime=20220310-15:38:15" target="_blank">Video of the speeches</a></td><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:01:10&amp;playerEndTime=20220310-15:38:15" target="_blank"><img width="5" height="20" src="/doceo/data/img/switch_pv_cre_right.gif" border="0" /></a></td></tr></table></td><td style="background-image:url(/doceo/data/img/gradient_blue.gif)" width="10"><table align="right" cellpadding="0" cellspacing="0"><tr><td><a href="/doceo/document/PV-9-2022-03-10-ITM-014_EN.html" title="Minutes"><img src="/doceo/data/img/switch_pv_cre_left.gif" width="22" height="20" border="0" alt="" /></a></td><td class="switch_button_pv_cre"><a href="/doceo/document/PV-9-2022-03-10-ITM-014_EN.html" title="Minutes">PV</a></td><td><a href="/doceo/document/PV-9-2022-03-10-ITM-014_EN.html" title="Minutes"><img src="/doceo/data/img/switch_pv_cre_right.gif" width="5" height="20" border="0" alt="" /></a></td></tr></table></td></tr></table>
<a name="4-147-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/2323.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:01:10&amp;playerEndTime=20220310-15:01:55" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Der Präsident.</span></span>   – Als nächster Punkt der Tagesordnung folgt die Aussprache über die Erklärung der Kommission zu einem systematischen Ansatz der EU in Bezug auf chronische Nierenerkrankungen (<a href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2022/2579(RSP)">2022/2579(RSP)</a>).</p>
<p class="contents">Ich erinnere die Mitglieder daran, dass es bei allen Aussprachen dieser Tagung keine spontanen Wortmeldungen gibt und dass keine blauen Karten akzeptiert werden.</p>
<p class="contents">Außerdem sind wie auch bei den letzten Tagungen Zuschaltungen aus den Verbindungsbüros des Parlaments in den Mitgliedstaaten vorgesehen.</p>
<p class="contents">Ich weise Sie auch darauf hin, dass Wortmeldungen im Plenarsaal weiterhin vom zentralen Rednerpult aus erfolgen. Ich ersuche Sie daher, die Rednerliste im Blick zu behalten und sich kurz vor Beginn Ihrer Redezeit zum Rednerpult zu begeben.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-148-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:01:54&amp;playerEndTime=20220310-15:08:39" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Stella Kyriakides,</span></span>   <span class="italic">Member of the Commission</span><span class="bold">.</span> – Mr President, it’s estimated that chronic kidney disease affects about one in ten Europeans and that alarmingly high number is expected to grow even further. As we all know, typical risk factors such as diabetes and hypertension are becoming more prevalent. If we add to that what we have learned, all of us, with the COVID—19 pandemic, we have seen that all patients with chronic diseases are at a higher risk to suffer a serious course of the infection. That’s why I’m really very happy that you have added this point on your agenda today, but also because I’ve had the opportunity in the last few months to have meetings with associations of patients with chronic disease so I have heard very closely and at first hand the many challenges they are facing. </p>
<p class="contents">As a Commission, we have not taken our eye off non-communicable diseases, while, of course, we have been fighting the pandemic together. On the contrary, I would say our efforts have been to help Member States deal with non-communicable diseases even more effectively. We provide support to Member States in their work to meet the United Nations Sustainable Development Goals and World Health Organization targets. This goes specifically for SDG Target 3.4, where the international community has subscribed to the goal to reduce premature mortality from non—communicable diseases by one third by 2030. We all know that this can only be done through prevention and treatment and by identifying and sharing best practices at both national and EU level.</p>
<p class="contents">To achieve this, we have a number of tools at our disposal. We recently launched a new EU initiative on non-communicable diseases called Healthier Together to address the leading causes of avoidable premature death. Healthier Together focuses on health promotion and prevention. At the same time, it supports improvements in every stage of a patient’s life, from screening and early diagnosis to early detection, treatment management and, of course, all important quality of life, along with improving knowledge and data availability. The priority strands of the initiative include cardiovascular diseases, diabetes, chronic respiratory diseases, mental health and neurological disorders. These are the leading causes of avoidable premature death, not including cancer.</p>
<p class="contents">As you know, diabetes and high blood pressure are among the main risk factors for chronic kidney disease. By working on these strands, we will also have a positive impact on kidney disease. The priorities and actions of this initiative will continuously be discussed with Member States and with stakeholders via the EU Health Policy Platform, and I will be very happy to be able to share with the European Parliament all progress made on these efforts. </p>
<p class="contents">We are all aware that this House has also made a priority Europe’s Beating Cancer Plan. This is a comprehensive plan, it is an ambitious plan and it foresees that we tackle health determinants such as tobacco use, nutrition, physical activity and alcohol. This will also help other non—communicable diseases like chronic kidney disease by addressing common risk factors. </p>
<p class="contents">Last but not least, we have our new EU4Health Programme. I will never stop thanking all the Members of this Parliament for their vocal support for that programme, which has given the EU4Health the resources to make it a real game-changer and bring about what I would say is a paradigm shift towards the stronger European health union that we’re all working together to build. This means we can support networks for knowledge-sharing and mutual learning, we can support capacity-building actions and strengthen strategic planning, and Member States will have more opportunities to exchange best practices. Indeed, a call under the 2022 EU4Health Programme for collecting and implementing evidence—based practices for non-communicable diseases specifically refers to chronic kidney disease. </p>
<p class="contents">The EU has funded many research actions under the Horizon 2020 programme. We have 40 projects directly addressing chronic kidney disease worth EUR 64 million and 24 projects related to kidney transplantation amounting to EUR 47 million. In the Horizon 2021 work programme our new flagship, the European Innovation Council, includes a call for medical technology and devices that includes portable dialysis. </p>
<p class="contents">So we are working strongly. We are working and supporting Member States in sharing best practices for organ donation and transplantation, where we all know that there are many challenges faced. We are working on digital transplant registries for the kidney transplant recipients and living kidney donors to be able to bring all the data together at EU level and to improve transplantation outcomes. </p>
<p class="contents">In ending, honourable Members, we fully appreciate the importance of research and of pooling knowledge, but more than that, we need to bring all this together to increase the quality of life and to increase the life expectancy of those living with chronic kidney disease. That’s why our support in this crucial area will not only continue, but I have personally committed to this to the patient organisations themselves. I look forward now to hearing your views on this very important matter. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-149-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/40599.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:08:55&amp;playerEndTime=20220310-15:12:18" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sirpa Pietikäinen, </span></span>  <span class="italic">on behalf of the PPE Group</span><span class="bold">.</span> – Mr President, I’m very happy that we are having this very frank and good exchange of opinions here in Parliament on kidney disease, like we have had on other diseases, where you have taken very prompt action. </p>
<p class="contents">We know that chronic kidney disease (CKD) is a significant burden for our healthcare system. One hundred million Europeans suffer from it, and predictions are that it is in sharp extension and increase. Of course, this is easy to understand. We live longer. We eat more medicine. There are the other big non-communicable diseases (NCDs) – we heard about diabetes and blood pressure. Then there’s our livelihoods and what we eat and what chemicals we put in ourselves – and that all gets into our kidneys. </p>
<p class="contents">But the difference with some other diseases, like the big ones like diabetes where we have the European programme, like heart and cardiovascular diseases, is that kidney disease is a silent killer. We do not raise it as a big issue at Member State level. </p>
<p class="contents">More often than not, patients are not aware of the situation until it is already a severe condition. Even though, in some cases, it would be preventable with different choices of medication, for example, if there’s a lack of understanding, prevention is undone. And then, if doctors often do not take it as a priority, the patients do not know, and the healthcare system doesn’t prioritise and understand it, and there you have it.</p>
<p class="contents">It keeps on growing and spreading silently in our societies. That’s why I think, and we co-signatories of this initiative think, that this would be a very good and proper time for the Commission to start thinking about having a separate kidney disease (CKD) programme that has the normal elements we always see in health programmes: how to prevent, how to diagnose early, how to screen, how to start the best treatments, how to develop better and more cost-effective treatments, as we know that this is one of the most expensive therapies we have in our healthcare system. </p>
<p class="contents">And with this, we can tackle this challenge. But I’m only afraid that if this is only one part of the NCD programme, and not even listed as one of the highest, we might not be able to tackle the challenge. </p>
<p class="contents">So this is the plea from us to the Commission: please consider having a separate programme about it and action in the future.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-150-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197718.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:12:30&amp;playerEndTime=20220310-15:14:56" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicolás González Casares, </span></span>  <span class="italic">en nombre del Grupo S&amp;D</span><span class="bold">.</span> – Señor presidente, señora comisaria, primero, me gustaría agradecer tener la posibilidad de debatir en el Parlamento Europeo sobre una enfermedad, la enfermedad renal crónica, que afecta a entre 75 y 100 millones de ciudadanos y ciudadanas europeos, que tiene un alto grado de infradiagnóstico porque no ponemos los medios adecuados y que, en algunos casos, puede ser prevenible. Y ha dicho la comisaria que el Plan Europeo de Lucha contra el Cáncer también interviene, con recomendaciones en salud pública, en el campo de la prevención. Pero, bueno, ya hemos visto que no se ha sido lo suficientemente ambicioso; yo creo que también siendo ambiciosos en esa prevención conseguiremos reducir la enfermedad renal crónica. </p>
<p class="contents">Los enfermos renales crónicos, además, sufren, sufren mucho durante su enfermedad. Los tratamientos son, además de costosos, duros, a veces exigen desplazamientos y, además, muchas veces se vive bajo la ansiedad de un trasplante. Pero, a pesar de todo eso, todos quieren y todos necesitan la posibilidad de recibir un tratamiento. Y hay muchas desigualdades en Europa para acceder a esos tratamientos. </p>
<p class="contents">Por lo tanto, le pedimos a la Comisión un plan de acción e inversiones. Sabemos que en Horizonte Europa lo está haciendo, pero, además, debe tomar buena cuenta de algunas iniciativas que existen en los diferentes países europeos. </p>
<p class="contents">Vengo de un país, España, donde tenemos un orgullo: nuestra Organización Nacional de Trasplantes, que marca récords a nivel europeo y mundial. Ese es un modelo que se puede seguir en Europa para buscar la igualdad. </p>
<p class="contents">Pero no nos salgamos del foco. Necesitamos nuevos tratamientos y que estos pacientes tengan nuevas oportunidades de tratamiento, que no se deje de investigar y que se investiguen también las causas de la enfermedad, porque a veces ayuda al tratamiento. </p>
<p class="contents">Me quiero acordar de aquellos pacientes a los que alguna vez traté o que iban a diálisis y tenían que desplazarse kilómetros y kilómetros, o que estaban en lista de espera para un trasplante, como mi amigo Fermín de O Corpiño, quien finalmente lo consiguió y ha mejorado su calidad de vida. Eso es lo que yo espero para todos los europeos y europeas. Que nos pongamos manos a la obra. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-151-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197466.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:15:05&amp;playerEndTime=20220310-15:18:59" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jutta Paulus, </span></span>  <span class="italic">on behalf of the Verts/ALE Group</span><span class="bold">.</span> – Mr President, I would like to say to Commissioner Kyriakides that she has described the problem very well and has already listed quite a few of the issues that the Commission is doing already, such as focusing on promotion and prevention, screening, diagnosis and knowledge data. </p>
<p class="contents">Commissioner Kyriakides, I’m glad that you are ready to take up the idea of having digital transplant registries in order to improve the situation of people that are waiting for an organ. But actually I missed a bit of the answer to part of our oral question, for example, when it comes to equitable deployment, when it comes to innovation and when it comes to greener dialysis. Actually, dialysis is still done in the same fashion as it was done 30 years ago when I was at university studying pharmacy. I think there has been so much progress in other parts of medicine and treatment that it is quite curious that this has not changed a lot and that it is still as time consuming, as resource consuming and as strenuous for patients as it was 30 years ago. I think that is really a realm where we should focus in our research activities and in our innovation programmes. I would really like to see an approach by the Commission which takes this into account.</p>
<p class="contents">We have repeatedly heard that, in the EU, 100 million people are suffering from chronic kidney disease. 9 874 people are currently waiting for an organ, and more than 3 000 of those have been waiting for more than five years. For these patients, going to dialysis three times a week, which is a time-consuming, strenuous and expensive exercise, and which also uses up a lot of energy and consumes a lot of plastic waste and lot of water, that should be our push for action. </p>
<p class="contents">We should also have a talk with Member States. I come from a Member State where organ transplantation is not as widespread an issue as it actually should be, because I know that there are other Member States – I’m looking to you, Ms Kyriakides! I would like you to address the Ministers of Health of the European Union in order to find how we can actually raise the numbers of people that are ready to donate an organ, for example, having a sort of default choice ‘Yes, I will donate organs’ instead of, as in Germany, where you have to opt in, not opt out. I think that would be the right way to address this issue in order, in three years, maybe no longer to have 10 000 people waiting for a kidney. And these are only kidneys. There are also things like livers and others. </p>
<p class="contents">The numbers on organ transplants are stagnating. They should actually go up because people should be aware of the problem, but they are not. I think the major lack is in screening and early detection because, when this disease is detected, people are already very ill. I think what we need is a really good training programme for the health workers on the front line. I would be very happy if you would support this at the Health Minister stage. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-152-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/132191.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:19:13&amp;playerEndTime=20220310-15:22:36" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Gunnar Beck, </span></span>  <span class="italic">im Namen der ID-Fraktion</span><span class="bold">.</span> – Herr Präsident! 100 Millionen Menschen – das hörten wir schon – leiden an chronischen Nierenerkrankungen, und laut Prognosen werden Nierenleiden bis 2040 die fünfthäufigste Todesursache weltweit sein. Die Nierenfunktion nimmt bei jedem Menschen ab dem 50. Lebensjahr um ein bis zwei Prozent jährlich ab. Kommen gewisse Risikofaktoren wie Diabetes, Übergewicht oder Bluthochdruck hinzu, kann sich die Funktion der Niere sogar um<span class="bold"> </span>bis zu 15 % jährlich verringern.</p>
<p class="contents">Nierenleiden sind eine menschliche, aber auch eine finanzielle Belastung für die Gesundheitssysteme. Die jährlichen Kosten in Europa betragen rund 140 Milliarden Euro – Tendenz steigend. Trotzdem hinkt die Erforschung neuer Therapien gegen chronische Nierenerkrankungen in Europa international hinterher. Den meisten Patienten ist ihr Gesundheitszustand aufgrund der fehlenden Frühdiagnose nicht bewusst – das Ergebnis auch eines Fachärztemangels an Nephrologen in Europa. </p>
<p class="contents">Die bevorzugte Behandlung von Nierenversagen im Endstadium ist die Transplantation. Doch die Wartezeit auf eine postmortale Organspende liegt bei 6 bis 8 Jahren. Die einzige Alternative ist die Dialyse. Daher werden in der EU nur 45 % der Intensivpatienten transplantiert, 55 % sind auf Dialyse angewiesen.</p>
<p class="contents">Wo können wir Geld einsparen, um Nierenpatienten zu helfen? Hier ein paar Vorschläge:</p>
<p class="contents">Das Europäische Institut für Gleichstellungsfragen hat ein Budget von fast 8 Millionen Euro, die wir sofort einsparen könnten. Der Asyl-, Migrations- und Integrationsfonds, der Nothilfefonds für Afrika und die Flüchtlingszahlungen an die Türkei kosten uns jährlich rund 5,5 Milliarden Euro, die ebenfalls eingespart werden könnten, wenn wir die Grenzen sicherten. Nebenbei: Die Bundesregierung lässt sich ihre Migrationspolitik mindestens 60 Milliarden Euro pro Jahr kosten, und die Klimarettung und die Energiepolitik kosten die Deutschen allein schon jetzt über 100 Milliarden Euro pro Jahr. Bedenken Sie die Dialysestunden, Ärzte, Pflegekräfte und Organspendekampagnen, die man damit einkaufen könnte.</p>
<p class="contents">Während wir jedes Jahr Hunderte Milliarden für Weltrettungsprojekte verschwenden, müssen wir heute hier im Europäischen Parlament um angemessene Mittel für 100 Millionen Menschen bitten, die dringend auf Gesundheitsversorgung angewiesen sind.</p>
<p class="contents">Damit es nicht gleich einen Aufschrei gibt: Wir sind nicht gegen Umweltschutz oder Ortshilfe für Flüchtlinge, nur gilt unsere erste Sorge Landsleuten und Europäern, vor allem wenn sie Not leiden oder erkranken.</p>
<p class="contents">Denn moralische Pflichten sind wie konzentrische Kreise – vom Nahen zum Fernen. Das sehen wir so, aber im Einvernehmen mit den Stoikern, Scholastikern, Immanuel Kant, den schottischen Moralisten oder auch Hegel. Nur wollen Sie von europäischer Kultur hier ja überhaupt nichts wissen. Denn Sie denken ja vornehmlich an ferne Länder, von denen wir wenig wissen.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-153-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/136236.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:22:45&amp;playerEndTime=20220310-15:26:10" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">João Pimenta Lopes, </span></span>  <span class="italic">em nome do Grupo The Left</span><span class="bold">.</span> – Senhor Presidente, Senhora Comissária, nos últimos anos tem-se verificado no mundo um aumento do número de doentes com doença renal crónica. A resposta a esta doença exige o reforço do serviço público e da resposta que dá na prevenção, controlo e tratamento da doença a par de apoios específicos aos doentes. </p>
<p class="contents">Uma doença que tem vários fatores de risco associados, nomeadamente a diabetes, hipertensão, obesidade, tabagismo, doenças pulmonares, entre outros, a que se tem que dar atenção com vista à introdução não só de medidas preventivas, mas também de medidas para a deteção precoce da doença. </p>
<p class="contents">Na Europa, estima-se em 75 milhões o número de pessoas com manifestação de algum dos estádios desta doença. Em Portugal, estima-se que uma em cada dez pessoas tenha algum estádio da doença, verificando-se uma das mais elevadas incidências a nível da Europa, com valores que oscilam entre os 218 e os 235 doentes por milhão de habitantes. </p>
<p class="contents">Estima-se que existam cerca de 20 mil doentes renais crónicos, em estágio cinco, em tratamento substitutivo renal, cerca de 60 % em hemodiálise, 37% de transplantados renais e menos de 4 % em diálise peritoneal. Por ano, mais de 2 mil doentes renais crónicos iniciam hemodiálise, constatando-se a ausência de serviços de proximidade para muitos dos doentes, obrigando-os a percorrer largas dezenas de quilómetros para os tratamentos. </p>
<p class="contents">Quase 50 % dos doentes têm como causa apontada outras patologias, a saber, a diabetes, (cerca de 30 %) e a hipertensão arterial (cerca de 15 %), as quais importa considerar com vista a adotar medidas preventivas primárias e de controlo da doença que impactem no desenvolvimento e na evolução da doença renal crónica. Sucede que cerca de 25 % dos doentes não tiveram seguimento em nefrologia antes de iniciarem a hemodiálise. </p>
<p class="contents">Importa reforçar igualmente a prevenção secundária com vista à identificação precoce da doença renal crónica, o que pode conduzir ao abrandamento da sua progressão, assim como a uma melhor preparação do doente e da sua família para o tratamento e as opções que existam. </p>
<p class="contents">Acresce que mais de 90 % dos doentes em hemodiálise são tratados em unidades privadas de hemodiálise convencionadas com o Estado, no essencial detidas por dois grandes grupos privados. No decurso da pandemia, contrariando períodos definidos pelas autoridades de saúde, assistiu-se a iniciativas de redução das sessões para três horas no lugar de quatro. Verifica-se, por sua vez, que muitos dos profissionais de saúde nestas unidades não têm um vínculo permanente, mas são sim contratados. Fica evidente que a preocupação não é assegurar o bem-estar dos doentes, mas sim a obtenção de lucro. </p>
<p class="contents">Por tudo isto, é fundamental alargar a resposta pública no Serviço Nacional de Saúde. A resposta à doença e os tratamentos de diálise devem ser incorporados no serviço público de saúde, incluindo respostas de proximidade a par do reforço dos profissionais de saúde e da sua valorização. </p>
<p class="contents">Importa ainda referir a dimensão humana e as dificuldades acrescidas que uma doença crónica comporta nas vidas dos doentes, com impactos que se traduzem no plano pessoal, familiar e laboral. São necessárias, por isso, medidas que garantam a proteção laboral destes doentes e a adequação do posto de trabalho, dos horários e das funções às limitações da doença, a par de outras como a isenção das taxas de saúde, o acesso gratuito à medicação e o tratamento da doença.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-154-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/197838.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:26:20&amp;playerEndTime=20220310-15:28:12" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Juozas Olekas (S&amp;D).</span></span>   – Gerbiamas Pirmininke, Komisijos nare, gerbiami kolegos. Paskutiniais porą metų sveikatos apsauga tapo aktyviai diskutuojama Europos Sąjungos mastu. Didysis kovos prieš vėžį planas ar vieningas atsakas į COVID-19 pandemiją ne tik padėjo užtikrinti geresnę sveikatos apsaugą Sąjungos piliečiams, bet ir parodė, jog sveikata Europos Sąjungoje turi būti reguliuojama bendrai.</p>
<p class="contents">Lėtinė inkstų liga, kuria Europoje serga apie 100 milijonų, prognozuojama, 2040 metais taps penkta dažniausia mirties priežastimi. Tai, jog liga dažnai prasideda besimptomiu pavidalu, yra diagnozuojama tik pažengusiose stadijose, sukelia rimtų iššūkių gydymui, o daugelis gyvybių, deja, yra prarandamos. Todėl privalu, kad visos Europos Sąjungos mastu ankstyvoji diagnozė būtų užtikrinta. Ypatingai rizikos grupėse, žmonėms, sergantiems sunkiomis ligomis, kaip diabetas, hipertenzija, širdies kraujagyslių ligos, vėžys, ar turintiems viršsvorio.</p>
<p class="contents">Dėmesį privalome atkreipti į dvi sritis. Pirma, daugelis antrinių ligų yra jautrios socialinei įtakai: depresija ar nerimas, – dažnai sukelti ekonominio nepritekliaus, nelygybės ar sudėtingų gyvenimo sąlygų, o dabar ir karo, – ypatingai labiausiai nepasiturintiems, dažnai veda prie streso, kuris sukelia dalį rizikos grupės ligų. Antra, privalome užtikrinti, kad ankstyvoji diagnozė bei technologinės inovacijos būtų vienodai prieinamos visose Europos Sąjungos šalyse. Tai reikalauja bendro Europinio reguliavimo ir sustiprintos Europos sveikatos sąjungos, kuri apimtų ne tik pasirengimą pandemijoms, bet ir kasdienių sveikatos problemų reguliavimą.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-155-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124867.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:28:20&amp;playerEndTime=20220310-15:30:00" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Brando Benifei (S&amp;D).</span></span>   – Signor Presidente, onorevoli colleghi, la mortalità correlata alle malattie renali continua ad aumentare ogni anno; si prevede sarà la quinta principale causa di morte entro il 2040. Inoltre, i dati parlano di circa 850 milioni di persone a livello mondiale che soffrono di una malattia renale, tra queste circa 13 milioni hanno avuto una malattia renale acuta pericolosa per la vita e 2,6 milioni hanno subito un trapianto o sono sottoposti a dialisi.</p>
<p class="contents">Informazione, prevenzione, diagnosi precoci possono fare la differenza per un percorso terapeutico ottimale e una migliore qualità della vita. Le disuguaglianze e ingiustizie sono tutt'oggi presenti nell'accesso alle cure per queste patologie. Il motivo per cui la malattia cronica è sottovalutata risiede nel fatto che questa progredisce per anni in maniera asintomatica.</p>
<p class="contents">In occasione della giornata mondiale del rene di oggi, 10 marzo 2022, il mio pensiero non può che andare ai pazienti affetti da malattia renale che si trovano in Ucraina; deve essere assolutamente garantita la continuità delle cure per la dialisi, i trapianti e l'assistenza sanitaria. Polonia, Romania, Slovacchia e Moldavia stanno attualmente fornendo cure essenziali ai profughi dializzati e trapiantati dall'Ucraina, ma si teme che le loro infrastrutture sanitarie locali saranno presto sovraccaricate; dobbiamo dare una mano, dobbiamo aiutare i paesi in prima linea.</p>
<p class="contents">Infine, voglio esprimere tutta la mia solidarietà e vicinanza ai medici, agli infermieri, a tutto il personale sanitario dell'Ucraina impegnati strenuamente in queste ore per garantire cure ai loro connazionali.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-156-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:30:18&amp;playerEndTime=20220310-15:36:17" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Stella Kyriakides,</span></span>   <span class="italic">Member of the Commission</span><span class="bold">.</span> – Mr President, honourable Members, I’ll start with the last comment I heard from Mr Benifei. You’re absolutely right that we need to support those frontline Member States who are receiving, on a daily basis, thousands and thousands of refugees because of the war in Ukraine. What I can assure you is that I am working, almost on a daily basis, with all those Health Ministers, and other Health Ministers, and we have now secured an initial first 10 000 beds in order to be able to transfer patients from those frontline Member States whose health systems are being severely pressed to other Member States who have come forward. These beds include general ward beds, oncology beds, burns units, neonatal beds with their mothers, paediatric beds, ICU and, of course, other diseases. So this is not coming, it is a priority and we are all working on it on a daily basis because we are facing a really tragic situation. In a war, it is the most vulnerable that are, of course, most affected, as all others.</p>
<p class="contents">Ms Pietikäinen, you are right that it’s almost a silent killer. Personally, I might not have been aware of this if I had not had three close friends in the last two years who needed dialysis, two of whom have had transplants. Reducing the burden of chronic kidney disease has become very evident. We are working on it, and I just want to tell you that there is a separate call for projects, which is open under the 2022 EU4Health work programme on non—communicable diseases, and this includes this.</p>
<p class="contents">Mr González Casares, we need to prioritise prevention. I totally agree and yes, as you mentioned, Spain has set an example for the work that you do with transplant and increasing donors. Good practices need to be exchanged between Member States. </p>
<p class="contents">Ms Paulus spoke of innovation, and I just want to say that, in our European Innovation Council, we included a call for medical technologies and devices that include portable dialysis. This is in part also to make the dialysis greener, in line with the latest science and technology, which is something that you mentioned. And we do need to do a great deal more on organ donation awareness. </p>
<p class="contents">Mr Pimenta Lopes, we need to do much more to raise awareness on organ donation and on how we can save lives. There are disparities between Member States on donation and transplantation and, following the EU action plan on organs, we saw the need to focus on the implementation of the developed knowledge in Member States. We need of course to bring in national authorities and professionals to take the lead on this in the different Member States by exchanging good practice. </p>
<p class="contents">Ms Olekas, on health there has been a paradigm shift. We can all see that. Early diagnosis is key, but prevention is really crucial. I want to say here because we are speaking of Europe’s Beating Cancer Plan, that the prevention pillar of Europe’s Beating Cancer Plan is so significant that it will impact on the prevention of other non-communicable diseases, and we are going to deliver on this plan. On innovative methods of treatment, we are coming forward with a new legislative proposal for the pharmaceutical legislation at the end of this year, which I will very much look forward to presenting to you. </p>
<p class="contents">Thank you for this very important exchange on the issues around chronic kidney disease. It’s essential that we address these challenges, that we work together among the Member States, that we never forget that those who have been hardest hit by COVID-19 are those with chronic illnesses, and that our healthier together programme will be able to bolster Member States’ actions on non-communicable diseases and risk factors which are common to many diseases, including chronic kidney disease. Let me repeat to you that we will be working on it continuously and with the Member States to share good practices, and we will make best use of the call under EU4Health. </p>
<p class="contents">Once again, thank you for putting it on the agenda today because, by using your voices, you also in a sense support the work that the Commission is doing and the commitment we have to change the world around non-communicable diseases. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-157-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/2323.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20220310-15:36:14&amp;playerEndTime=20220310-15:38:15" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Der Präsident.</span></span>   – Die Aussprache ist geschlossen.</p>
<p class="contents">Wir haben jetzt zuletzt dieses ernste Thema gehabt. Wir beenden eine schwierige Woche. Wir haben jetzt zwei Jahre und einen Monat Pandemie. Vor zwei Jahren und einem Monat waren wir zum letzten Mal hier. Jetzt sind wir wieder hier. In der nächsten Woche werden wir erstmals wieder Besucher empfangen können. Und jetzt, nach zwei Jahren und einem Monat, nach der Pandemie, kommen diese schrecklichen Nachrichten, die uns alle betreffen und bedrücken.</p>
<p class="contents">Nach dem Brexit, nach der Pandemie und diesem Überfall auf ein unabhängiges Land auf unserem Kontinent werden wir zum dritten Mal in kurzer Zeit daran erinnert, dass wir vieles auf diesem Kontinent gemeinsam schneller und besser erreichen können.</p>
<p class="contents">Lassen Sie uns zusammenbleiben, lassen Sie uns zusammenhalten, lassen Sie uns bewusster werden, Bewusstsein entwickeln für das, was wir haben. Es ist kostbar, es ist zerbrechlicher, es ist flüchtiger, als wir manchmal denken. Es ist jedenfalls weniger selbstverständlich, als manche glauben. Lassen Sie uns an die denken, die in diesen Tagen um Freiheit, Frieden und Demokratie kämpfen und die erfahren, dass all dies eben gerade nicht selbstverständlich ist.</p>
<p class="contents">Die Sitzung wird um 16.00 Uhr mit der Bekanntgabe der Abstimmungsergebnisse wieder aufgenommen.</p>
<p class="contents"><span class="italic">(Die Sitzung wird um 15.38 Uhr unterbrochen)</span></p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td>Last updated: 1 July 2022</td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
